ObjectiveThere is an increasing need for vascular grafts in the field of surgical revascularization. However, smaller vascular grafts made from synthetic biomaterials, particularly those <5 mm in diameter, are associated with a high incidence of thrombosis. Fibroin is a biodegradable protein derived from silk. Silk fibroin from Bombyx mori provides an antithrombotic surface and serves as a scaffold for various cell types in tissue engineering. We evaluated the potential of fibroin to generate a vascular prosthesis for small arteries.MethodsA small vessel with three layers was woven from silk fibroin thread. These fibroin-based grafts (1.5 mm diameter, 10 mm length) were implanted into the abdominal aorta of 10- to 14-week-old male Sprague-D...
<div><p>The surgical repair of heart and vascular disease often requires implanting synthetic grafts...
Fibrin is a very attractive material for the development of tissue-engineered scaffolds due to its e...
For small diameter (<6 mm) blood vessel replacements, lack of collaterals and vascular disease precl...
ObjectiveThere is an increasing need for vascular grafts in the field of surgical revascularization....
Aim: Synthetic vascular grafts are widely used in surgical revascularization, mainly for medium- to ...
Purpose: There is an increasing need for vascular grafts in the field of surgical revascularization....
To address the need of alternatives to autologous vessels for small-calibre vascular applications (e...
Silk fibroin (SF) is an eligible biomaterial for the development of small caliber vascular grafts fo...
As the incidence of cardiovascular diseases has been growing in recent years, the need for small-dia...
Cardiovascular diseases are the leading cause of mortality around the globe, and microvasculature re...
There is a clinical need for tissue-engineered small-diameter (<6 mm) vascular grafts since clinical...
Synthetic vascular grafts for small diameter revascularization are lacking. Clinically available con...
ObjectiveTo evaluate a new Hyaluronan-based graft.Material and methodsHyaluronan-based grafts (HYAFF...
Cardiovascular disease is the leading cause of death worldwide and patients often require surgical b...
Silk fibroin (SF), a natural polymer material possessing excellent biocompatibility and biodegradabi...
<div><p>The surgical repair of heart and vascular disease often requires implanting synthetic grafts...
Fibrin is a very attractive material for the development of tissue-engineered scaffolds due to its e...
For small diameter (<6 mm) blood vessel replacements, lack of collaterals and vascular disease precl...
ObjectiveThere is an increasing need for vascular grafts in the field of surgical revascularization....
Aim: Synthetic vascular grafts are widely used in surgical revascularization, mainly for medium- to ...
Purpose: There is an increasing need for vascular grafts in the field of surgical revascularization....
To address the need of alternatives to autologous vessels for small-calibre vascular applications (e...
Silk fibroin (SF) is an eligible biomaterial for the development of small caliber vascular grafts fo...
As the incidence of cardiovascular diseases has been growing in recent years, the need for small-dia...
Cardiovascular diseases are the leading cause of mortality around the globe, and microvasculature re...
There is a clinical need for tissue-engineered small-diameter (<6 mm) vascular grafts since clinical...
Synthetic vascular grafts for small diameter revascularization are lacking. Clinically available con...
ObjectiveTo evaluate a new Hyaluronan-based graft.Material and methodsHyaluronan-based grafts (HYAFF...
Cardiovascular disease is the leading cause of death worldwide and patients often require surgical b...
Silk fibroin (SF), a natural polymer material possessing excellent biocompatibility and biodegradabi...
<div><p>The surgical repair of heart and vascular disease often requires implanting synthetic grafts...
Fibrin is a very attractive material for the development of tissue-engineered scaffolds due to its e...
For small diameter (<6 mm) blood vessel replacements, lack of collaterals and vascular disease precl...